Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic ...

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

It would give millions of people access to weekly injectables that have helped people shed pounds so quickly that some people ...

Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...

For some, the issue with GLP-1 drugs like Ozempic and Mounjaro isn't getting access to these game-changing medications, but ...

Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...

Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by ...

But their weight-loss properties grabbed the attention of the public and people without diabetes started seeking these drugs.

The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...